mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P262
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rubin-Bejerano, Ifat
Sansal-Castellano, Isabelle
Carlson, Mark
Reznik, Gabriel
Siedlecki, James
Kane, John
Dostalova, Zuzana
Miao, Hua
Article History
First Online: 6 November 2014